|
|
Volumn 358, Issue 9294, 2001, Pages 1703-
|
|
Molecular decoy may keep bypass grafts open.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELL CYCLE PROTEIN;
DNA BINDING PROTEIN;
TRANSCRIPTION FACTOR;
TRANSCRIPTION FACTOR E2F;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY BYPASS GRAFT;
CORONARY BLOOD VESSEL;
DRUG ANTAGONISM;
DRUG EFFECT;
GRAFT SURVIVAL;
HUMAN;
PATHOLOGY;
RANDOMIZED CONTROLLED TRIAL;
CELL CYCLE PROTEINS;
CORONARY ARTERY BYPASS;
CORONARY VESSELS;
DNA-BINDING PROTEINS;
E2F TRANSCRIPTION FACTORS;
GRAFT SURVIVAL;
HUMANS;
TRANSCRIPTION FACTORS;
|
|
EID: 0035904829
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(01)06772-1 Document Type: Article |
|
Times cited : (9)
|
|
References (0)
|
